Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Randomized Controlled Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children With Suspected, Isolated Extremity Fractures in the Pediatric Emergency Department


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02521415

Organisation Name: Wake Forest University Health Sciences

Overal Status: Completed

Start Date: December 2015

Last Update: July 26, 2022

Lead Sponsor: Wake Forest University Health Sciences

Brief Summary: This single center, randomized control, double blind trial will prospectively examine the feasibility of intranasal, sub-dissociative (IN) ketamine versus intranasal fentanyl for pain control in the pediatric emergency department setting. The investigators hypothesize that IN ketamine may provide a safe and effective alternative to IN fentanyl for children with suspected, isolated extremity fractures.

Eighty children ages 3-17 years with a suspected, isolated extremity fracture that requires analgesia will be randomized to receive IN ketamine or IN fentanyl upon presentation to the emergency department and will be followed for 2 hours for efficacy and 6 hours for safety.

Conditions:
  • Bone Fracture


Total execution time in seconds: 2.8885259628296